Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CTKB advanced for three days, in 229 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on CTKB as a result. In 58 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for CTKB just turned positive on October 26, 2026. Looking at past instances where CTKB's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 101 of 139 cases where CTKB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The 10-day RSI Indicator for CTKB moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 18 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTKB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
CTKB broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.475) is normal, around the industry mean (4.201). P/E Ratio (-9.730) is within average values for comparable stocks, (1.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (3.064) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CTKB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TXG declined for three days, in 267 of 324 cases, the price declined further within the following month. The odds of a continued downward trend are 82%.
The 10-day RSI Indicator for TXG moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 25 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 54 cases where TXG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for TXG turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
TXG moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
TXG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on TXG as a result. In 75 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The 10-day moving average for TXG crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +14.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where TXG advanced for three days, in 207 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 200 of 232 cases where TXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.065) is normal, around the industry mean (4.201). P/E Ratio (-118.831) is within average values for comparable stocks, (1.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (15.038) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
TXG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 93 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CTKB | TXG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 78% |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 86% |
| MACD ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| Advances ODDS (%) | 3 days ago 78% | 4 days ago 78% |
| Declines ODDS (%) | 25 days ago 84% | 2 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CTKB’s FA Score shows that 1 FA rating(s) are green while TXG’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CTKB’s TA Score shows that 4 TA indicator(s) are bullish while TXG’s TA Score has 4 bullish TA indicator(s).
CTKB (@Medical/Nursing Services) experienced а +9.66% price change this week, while TXG (@Medical/Nursing Services) price change was -2.01% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -8.74%, and the average quarterly price growth was -9.59%.
CTKB is expected to report earnings on Nov 04, 2026.
TXG is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with CRL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To CTKB | 1D Price Change % | ||
|---|---|---|---|---|
| CTKB | 100% | -2.70% | ||
| CRL - CTKB | 44% Loosely correlated | -4.44% | ||
| RVTY - CTKB | 42% Loosely correlated | -5.30% | ||
| TXG - CTKB | 39% Loosely correlated | -14.03% | ||
| A - CTKB | 39% Loosely correlated | -3.47% | ||
| UTMD - CTKB | 38% Loosely correlated | +1.91% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLU | 43.43 | 0.29 | +0.67% |
| State Street Utilities Select Sector SPDR ETF (XLU) | |||
| ENZL | 44.81 | 0.27 | +0.61% |
| iShares MSCI New Zealand ETF (ENZL) | |||
| MYMI | 24.34 | 0.12 | +0.50% |
| State Street My2029 Municipal Bond ETF (MYMI) | |||
| MLPB | 30.05 | 0.10 | +0.32% |
| ETRACS Alerian MLP Infrastructure Index ETN Series B (MLPB) | |||
| SDCI | 31.11 | -0.22 | -0.70% |
| USCF SummerHaven Dynamic Commodity Strategy No K-1 Fund (SDCI) | |||